Delivery Order SPE2DB22D2009-SPE2DB25FL8AK
Award Date
2/25/25
Potential Completion Date
2/26/25
Potential Value
$3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,338.94, is for the procurement of Chloraseptic Max 15-10 mg lozenges. The contract is a firm fixed-price delivery order, with a period of performance through January 8, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $3,503.81, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of Chloraseptic Max 15-10 mg lozenges to support military healthcare programs. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999, which serves as a primary vehicle for Amerisourcebergen to provide a comprehensive...
This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Chloraseptic Max 15-10 mg Lozenges. The $2,054.66 firm-fixed-price contract has an ultimate completion date of August 7, 2024. AmerisourceBergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999 through December 2025, which serves as the primary vehicle for providing a...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,461.01 firm fixed-price delivery order is for the supply of Chloraseptic Max 15-10 mg Lozenges. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,156.09 firm fixed-price delivery order is for the supply of Chloraseptic Max 15-10 mg lozenges to support military healthcare programs. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is a delivery order with a firm fixed price valued at $1,457.47, issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4566405605 - CHLORASEPTIC MAX 15-10 MG LOZ 15S, with a period of performance through November 13, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award, valued at $1,253.23, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company. The award is for the delivery of Chloraseptic Max 15-10 mg lozenges under a Firm Fixed Price contract type. The contract has an ultimate completion date of September 5, 2024. This award does not utilize a set-aside designation. AmerisourceBergen, as the prime contractor, will be responsible for supplying these...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,825.86 firm-fixed-price delivery order is for "CHLORASEPTIC MAX 15-10 MG LOZ 15S", a pharmaceutical product. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award is for the delivery of CHLORASEPTIC MAX 15-10 MG LOZ 15S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a total ceiling value of $3,706.92 and an ultimate completion date of December 24, 2024. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition....
The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at thirty-one thousand five hundred fifty-nine dollars to Amerisourcebergen Drug Corporation for chloraseptic lozenges. Under this contract, Amerisourcebergen will deliver fifteen hundred boxes of Chloraseptic MAX 15-10 mg lozenges to a facility in Conshohocken, Pennsylvania by July twenty-fifth, twenty twenty-three. The Defense Logistics Agency manages the Department of Defense's global logistics...